Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain
  2. Spuches, A. M.; Argiros, H. J.; Lee, K. H.; Haas, L. L.; Perch, S. C.; Krag, D. N.; Roller, P. P.; Wilcox, D. E.; Lyons, B. A.
  3. Journal of Molecular Recognition. 2007, Jul-Aug; 20(4): 245-252.
  1. 2.   Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics
  2. Jiang, S.; Li, P.; Peach, M. L.; Bindu, L.; Worthy, K. W.; Fisher, R. J.; Burke, T. R.; Nicklaus, M.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2006, Oct; 349(2): 497-503.
  1. 3.   Design and concise synthesis of fully protected analogues of L-gamma-carboxyglutamic acid
  2. Jiang, S.; Li, P.; Lai, C. C.; Kelley, J. A.; Roller, P. P.
  3. Journal of Organic Chemistry. 2006, Sep; 71(19): 7307-7314.
  1. 4.   A practical synthesis of fully protected L-gamma-carboxyglutamic acid
  2. Jiang, S.; Lai, C. C.; Kelley, J. A.; Roller, P. P.
  3. Tetrahedron Letters. 2006, Jan; 47(1): 23-25.
  1. 5.   Crystal structures of a high-affinity macrocyclic peptide mimetic in complex with the Grb2 SH2 domain
  2. Phan, J.; Shi, Z. D.; Burke, T. R.; Waugh, D. S.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 104-115.
  1. 6.   Synthesis of a C-terminally biotinylated macrocyclic peptide mimetic exhibiting high Grb2 SH2 domain-binding affinity
  2. Shi, Z. D.; Liu, H. P.; Zhang, M. C.; Worthy, K. M.; Bindu, L.; Yang, D. J.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2005, JUL 1; 13(13): 4200-4208.
  1. 7.   Examination of phosphoryl-mimicking functionalities within a macrocyclic Grb2 SH2 domain-binding platform
  2. Kang, S. U.; Shi, Z. D.; Worthy, K. M.; Bindu, L. K.; Dharmawardana, P. G.; Choyke, S. J.; Bottaro, D. P.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2005, JUN 16; 48(12): 3945-3948.
  1. 8.   Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin
  2. Shi, Y. H.; Song, Y. L.; Lin, D. H.; Tan, J. Z.; Roller, P. P.; Li, Q.; Long, Y. Q.; Song, G. Q.
  3. Biochemical and Biophysical Research Communications. 2005, MAY 20; 330(4): 1254-1261.
  1. 9.   Ring-closing metathesis of C-terminal allylglycine residues with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic as an approach to novel Grb2 SH2 domain-binding macrocycles
  2. Oishi, S.; Shi, Z. D.; Worthy, K. M.; Bindu, L. K.; Fisher, R. J.; Burke, T. R.
  3. Chembiochem. 2005, APR; 6(4): 668-674.
  1. 10.   Utilization of a nitrobenzoxadiazole (NBD) fluorophore in the design of a Grb2 SH2 domain-binding peptide mimetic
  2. Shi, Z. D.; Karki, R. G.; Oishi, S.; Worthy, K. M.; Bindu, L. K.; Dharmawardana, P. G.; Nicklaus, M. C.; Bottaro, D. P.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2005, MAR 1; 15(5): 1385-1388.
  1. 11.   Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics
  2. Oishi, S.; Karki, R. G.; Kang, S. U.; Wang, X. Z.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2005, FEB 10; 48(3): 764-772.
  1. 12.   Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic
  2. Oishi, S.; Karki, R. G.; Shi, Z. D.; Worthy, K. M.; Bindu, L.; Chertov, O.; Esposito, D.; Frank, P.; Gillette, W. K.; Maderia, M.; Hartley, J.; Nicklaus, M. C.; Barchi, J. J.; Fisher, R. J.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry. 2005 13(7): 2431-2438.
  1. 13.   Utilization of a common pathway for the synthesis of high affinity macrocyclic Grh2 SH2 domain-binding peptide mimetics that differ in the configuration at one ring junction
  2. Shi, Z. D.; Karki, R. G.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Chemistry & Biodiversity. 2005 2(4): 447-456.
  1. 14.   Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface resonance plasmon technology
  2. Lung, F. D. T.; Chang, C. W.; Chong, M. C.; Liou, C. C.; Li, P.; Peach, M. L.; Nicklaus, M. C.; Lou, B. S.; Roller, P. P.
  3. Peptide Science (Biopolymers). 2005 80(5): 628-635.
  1. 16.   Design and synthesis biotinylated ligands exhibiting high GRB2 SH2 domain-binding affinity
  2. Shi, Z. D.; Liu, H. P.; Zhang, M.; Roberts, L. R.; Fisher, R. J.; Yang, D. J.; Bottaro, D.; Linehan, M.; Burke, T. R.
  3. Abstracts of Papers of the American Chemical Society. 2004, AUG 22; 228(Part 1): 242-MEDI, Abstract U951-242-MEDI, Abstract U951.
  1. 17.   Examination of the role of phosphoryl-mimicking functionality in the binding of picomolar-affinity Grb2 SH2 domain-binding macrocycles
  2. Kang, S.; Shi, Z. D.; Lee, K.; Worthy, K. M.; Fisher, R. J.; Burke, T. R.
  3. Abstracts of Papers of the American Chemical Society. 2004, MAR 28; 227(041-MEDI, Part 2): U12-U12.
  1. 18.   Design, synthesis and utilization of biotinylated macrocyclic Grb2 SH2 domain-binding ligands
  2. Shi, Z. D.; Lee, K.; Liu, H. P.; Zhang, M. C.; Roberts, L. R.; Fisher, R. J.; Yang, D. J.; Bottaro, D.; Linehan, M.; Burke, T. R.
  3. Abstracts of Papers of the American Chemical Society. 2004, MAR 28; 227(040-MEDI, Part 2): U12-U12.
  1. 19.   Synthesis of a 5-methylindolyl-containing macrocycle that displays ultrapotent Grb2 SH2 domain-binding affinity
  2. Shi, Z. D.; Lee, K.; Wei, C. Q.; Roberts, L. R.; Worthy, K. M.; Fisher, R. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2004 47(4): 788-791.
  1. 20.   Macrocyclization in the design of non-phosphorus-containing Grb2 SH2 domain-binding ligands
  2. Shi, Z. D.; Wei, C. Q.; Lee, K. O.; Liu, H. P.; Zhang, M. C.; Araki, T.; Roberts, L. R.; Worthy, K. M.; Fisher, R. J.; Neel, B. G.; Kelley, J. A.; Yang, D. J.; Burke, T. R.
  3. Journal of Medicinal Chemistry. 2004 47(8): 2166-2169.
  1. 21.   Development of L-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity
  2. Song, Y. L.; Roller, P. P.; Long, Y. Q.
  3. Bioorganic & Medicinal Chemistry Letters. 2004 14(12): 3205-3208.
  1. 22.   Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain
  2. Long, Y. Q.; Guo, R. B.; Luo, J. H.; Yang, D. J.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2003 310(2): 334-340.
  1. 23.   Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity
  2. Li, P.; Zhang, M. C.; Peach, M. L.; Zhang, X. D.; Liu, H. P.; Nicklaus, M.; Yang, D. J.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2003 307(4): 1038-1044.
  1. 24.   Design and synthesis of potent Grb2-SH2 domain antagonists based upon phage library derived cyclic peptide G1TE
  2. Li, P.; Zhang, M. C.; Peach, M. L.; Yang, D. J.; Roller, P. P.
  3. Abstracts of Papers of the American Chemical Society. 2003 225(Part 2): U192-U192.
  1. 25.   Macrocyclization in the design of non phosphorus-containing GRB2 SH2 domain-binding ligands that exhibit high affinity in cell-based assays
  2. Shi, Z. D.; Wei, C. Q.; Gao, Y.; Lee, K.; Vasselli, J.; Zhang, M. C.; Liu, H. P.; Yang, D. J.; Linehan, M.; Burke, T. R.
  3. Abstracts of Papers of the American Chemical Society. 2003 225(Part 2): U174-U174.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel